Skip to main content
OpenTrials

Clinical trial condition

Disease Attributes

Explore clinical trials studying Disease Attributes. Study availability and eligibility vary by location and protocol.

21,324 public trials 3,089 recruiting studies
Refine in advanced search Browse all conditions

Disease Attributes trial results

Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

NCT07281430

Conditions
Cervical Carcinoma, Communicable Diseases, DNA Virus Infections, +23 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Louisiana State University Lafayette, Louisiana, United States
  • Louisiana State University Health Science Center New Orleans, Louisiana, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT07306832

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Lucile Packard Children's Hospital /ID# 276015 Palo Alto, California, United States
  • New York Medical College /ID# 275597 Valhalla, New York, United States
  • Tristar Centennial Medical Center /ID# 275831 Nashville, Tennessee, United States
  • Perth Children'S Hospital /ID# 275673 Perth, Western Australia, Australia
View Trial Details
Recruiting

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

NCT07342478

Conditions
CLL, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, +23 more
Locations
  • The Center for Cancer and Blood Disorders-Bethesda Bethesda, Maryland, United States
  • Optum Medical Group (Rhodes) P.C. Las Vegas, Nevada, United States
  • OSU Comprehensive Cancer Center Columbus, Ohio, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

NCT06708897

Conditions
Blood Protein Disorders, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, +32 more
Locations
  • Norton Cancer Institute, St. Matthews Campus Louisville, Kentucky, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details

Related conditions